Background/Aims: To investigate clinical outcomes of remote peritoneal dialysis (PD) patients in Southern China. Methods: In this retrospective cohort study, incident remote PD patients managed with a comprehensive follow-up program in our PD center were included and clinical outcomes were estimated. Results: One thousand and five remote PD patients with mean age 46.1 ± 14.6 years, of which 38.1% were women, were followed-up for a median of 35.7 months. Patient survival rates were 95.4, 84.7 and 71.8% and death-censored technique survival rates were 98.6, 92.3 and 83.4% at 1, 3 and 5 years, respectively. Peritonitis rate was 0.16 episodes per patient-year. Advanced age, diabetes mellitus, shorter peritonitis-free survival time, poor compliance for regular visiting nephrologists and lower hemoglobin predicted all-cause mortality of remote PD patients. Conclusion: The remote PD patients in Southern China managed with comprehensive follow-up program had favorable clinical outcomes, which indicated that home-based PD therapy could be an appropriate treatment option for remote end-stage kidney disease patients.

Keywords:
Outcomes, Peritoneal dialysis, Remote areas, Comprehensive follow-up program
1.
Bargman JM: Advances in peritoneal dialysis: a review. Semin Dial 2012;25:545-549.
2.
Tonelli M, Hemmelgarn B, Culleton B, Klarenbach S, Gill JS, Wiebe N, Manns B; Alberta Kidney Disease Network: Mortality of Canadians treated by peritoneal dialysis in remote locations. Kidney Int 2007;72:1023-1028.
3.
Maripuri S, Arbogast P, Ikizler TA, Cavanaugh KL: Rural and micropolitan residence and mortality in patients on dialysis. Clin J Am Soc Nephrol 2012;7:1121-1129.
4.
Yan G, Cheung AK, Ma JZ, Yu AJ, Greene T, Oliver MN, Yu W, Norris KC: The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. Clin J Am Soc Nephrol 2013;8:610-618.
5.
Mehrotra R, Story K, Guest S, Fedunyszyn M: Neighborhood location, rurality, geography, and outcomes of peritoneal dialysis patients in the United States. Perit Dial Int 2012;32:322-331.
6.
Yang X, Mao HP, Guo QY, Yu XQ: Successfully managing a rapidly growing peritoneal dialysis program in Southern China. Chin Med J (Engl) 2011;124:2696-2700.
7.
Yu X, Yang X, Huang N: Management of a rapidly growing peritoneal dialysis population at the First Affiliated Hospital of Sun Yat-sen University. Perit Dial Int 2014;34(suppl 2):S31-S34.
8.
Yu X, Yang X: Peritoneal dialysis in China: meeting the challenge of chronic kidney failure. Am J Kidney Dis 2015;65:147-151.
9.
Jiang Z, Yu X: Advancing the use and quality of peritoneal dialysis by developing a peritoneal dialysis satellite center program. Perit Dial Int 2011;31:121-126.
10.
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-1197.
11.
Chang TI, Kang EW, Lee YK, Shin SK: Higher peritoneal protein clearance as a risk factor for cardiovascular disease in peritoneal dialysis patient. PLoS One 2013;8:e56223.
12.
Volk ML, Hernandez JC, Lok AS, Marrero JA: Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl 2007;13:1515-1520.
13.
Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG: Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010;30:393-423.
14.
Xu Y, Dong J, Zuo L: Is frequency of patient-physician clinic contact important in peritoneal dialysis patients. Perit Dial Int 2009;29(suppl 2):S83-S89.
15.
Sanabria M, Devia M, Hernández G, Astudillo K, Trillos C, Uribe M, Latorre C, Bernal A, Rivera A; Local investigators in study: Outcomes of a peritoneal dialysis program in remote communities within Colombia. Perit Dial Int 2015;35:52-61.
16.
Gray NA, Grace BS, McDonald SP: Peritoneal dialysis in rural Australia. BMC Nephrol 2013;14:278.
17.
Cho Y, Badve SV, Hawley CM, McDonald SP, Brown FG, M NB, Wiggins KJ, Bannister KM, Clayton P, Johnson DW: The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. BMC Nephrol 2012;13:41.
18.
Nayak A, Antony S, Nayak KS: Remote monitoring of peritoneal dialysis in special locations. Contrib Nephrol 2012;178:79-82.
19.
Rosner MH, Ronco C: Remote monitoring for continuous peritoneal dialysis. Contrib Nephrol 2012;178:68-73.
20.
Li J, Wang H, Xie H, Mei G, Cai W, Ye J, Zhang J, Ye G, Zhai H: Effects of post-discharge nurse-led telephone supportive care for patients with chronic kidney disease undergoing peritoneal dialysis in China: a randomized controlled trial. Perit Dial Int 2014;34:278-288.
21.
Chand DH, Bednarz D: Daily remote peritoneal dialysis monitoring: an adjunct to enhance patient care. Perit Dial Int 2008;28:533-537.
22.
Wagner M, Ansell D, Kent DM, Griffith JL, Naimark D, Wanner C, Tangri N: Predicting mortality in incident dialysis patients: an analysis of the United Kingdom renal registry. Am J Kidney Dis 2011;57:894-902.
23.
Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim BS, Kang SW, Choi KH, Han DS, Lee HY: Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit Dial Int 2007;27:432-440.
24.
Joshi U, Guo Q, Yi C, Huang R, Li Z, Yu X, Yang X: Clinical outcomes in elderly patients on chronic peritoneal dialysis: a retrospective study from a single center in China. Perit Dial Int 2014;34:299-307.
25.
Fan X, Huang R, Wang J, Ye H, Guo Q, Yi C, Lin J, Zhou Q, Shao F, Yu X, Yang X: Risk factors for the first episode of peritonitis in Southern Chinese continuous ambulatory peritoneal dialysis patients. PLoS One 2014;9:e107485.
26.
Portoles J, Janeiro D, Lou-Arnal LM, Lopez-Sanchez P, Ortega M, del Peso G, Felipe C, Tato AM, Velo M, Castellano I, Perez-Diaz V; Grupo Centro de Diálisis Peritoneal (GCDP): First episodes of peritoneal infection: description and prognostic factors. Nefrologia 2013;33:316-324.
27.
Yang X, Yi C, Liu X, Guo Q, Yang R, Cao P, Lin J, Mao H, Yu X: Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study. Diabetes Res Clin Pract 2013;100:354-361.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.